TCL Archive Interview with Mark Ratain: Too Much Emphasis On Precision, Not Enough Emphasis On Accuracy In Dosing October 8, 2010
TCL Archive FDA Requires Independent Confirmation of Disease Progression in Cooperative Group Trials; Seeks Documentation for Avastin in Breast Cancer. September 15, 2006
TCL Archive In Senate testimony, NCI director uses survival rate as measure of progress for goal to “eliminate suffering and death due to cancer.” July 29, 2005
TCL Archive NCI Critics Take Their Best Shots, Seek New Emphasis On Prevention At Kennedy Hearings March 16, 1979
